Bortezomib/dexamethasone

( DrugBank: Bortezomib, Dexamethasone / KEGG DRUG: Bortezomib, Dexamethasone )

1 disease

ID	Disease name (Link within this page)	Number of trials
283	Acquired pure red cell aplasia	1

283. Acquired pure red cell aplasia

Clinical trials : 19 / Drugs : 36 - (DrugBank : 23) / Drug target genes : 20 - Drug target pathways : 102

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04423367 (ClinicalTrials.gov)	September 13, 2020	5/6/2020	Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line ...	Safety and Efficacy of Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or R ...	Acquired Pure Red Cell Aplasia	Drug: bortezomib/dexamethasone	Institute of Hematology & Blood Diseases Hospital	NULL	Recruiting	18 Years	70 Years	All	17	Phase 2	China

First Previous1Next Last